The Cancer Genome Atlas NetworkComprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015;517:576–82.
Google Scholar
Johnson DE, Burtness B, Leemans CR, Lui VWY, Bauman JE, Grandis JR. Head and neck squamous cell carcinoma. Nat Rev Dis Prim. 2020;6:92.
Google Scholar
Sharpless NE, Ramsey MR, Balasubramanian P, Castrillon DH, DePinho RA. The differential impact of p16INK4a or p19ARF deficiency on cell growth and tumorigenesis. Oncogene. 2004;23:379–85.
Google Scholar
Moore L, Venkatachalam S, Vogel H, Watt JC, Wu CL, Steinman H, et al. Cooperativity of p19ARF, Mdm2, and p53 in murine tumorigenesis. Oncogene. 2003;22:7831–7.
Google Scholar
Sharpless NE, Alson S, Chan S, Silver DP, Castrillon DH, DePinho RA. p16(INK4a) and p53 deficiency cooperate in tumorigenesis. Cancer Res. 2002;62:2761–5.
Google Scholar
Kelly-Spratt KS, Gurley KE, Yasui Y, Kemp CJ. p19Arf suppresses growth, progression, and metastasis of Hras-driven carcinomas through p53-dependent and -independent pathways. PLoS Biol. 2004;2:e242.
Google Scholar
Hamad SH, Sellers RS, Wamsley N, Zolkind P, Schrank TP, Major MB, et al. NRF2 activation in Trp53;p16-deficient mice drives oral squamous cell carcinoma. Cancer Res Commun. 2024;4:487–95.
Google Scholar
Tang XH, Knudsen B, Bemis D, Tickoo S, Gudas LJ. Oral cavity and esophageal carcinogenesis modeled in carcinogen-treated mice. Clin Cancer Res. 2004;10:301–13.
Google Scholar
Sequeira I, Rashid M, Tomás IM, Williams MJ, Graham TA, Adams DJ, et al. Genomic landscape and clonal architecture of mouse oral squamous cell carcinomas dictate tumour ecology. Nat Commun. 2020;11:5671.
Google Scholar
Ishida K, Tomita H, Kanayama T, Noguchi K, Niwa A, Kawaguchi M, et al. Specific deletion of p16INK4a with retention of p19ARF enhances the development of invasive oral squamous cell carcinoma. Am J Pathol. 2020;190:1332–42.
Google Scholar
Meisel CT, Pagella P, Porcheri C, Mitsiadis TA. Three-dimensional imaging and gene expression analysis upon enzymatic isolation of the tongue epithelium. Front Physiol. 2020;11:825.
Google Scholar
Seubert AC, Krafft M, Kretzschmar K. Generation and characterization of murine oral mucosal organoid cultures. J Vis Exp. 2021;173:e62529.
Puram SV, Tirosh I, Parikh AS, Patel AP, Yizhak K, Gillespie S, et al. Single-cell transcriptomic analysis of primary and metastatic tumor ecosystems in head and neck cancer. Cell. 2017;171:1611–24.
Google Scholar
Korgaonkar C, Zhao L, Modestou M, Quelle DE. ARF function does not require p53 stabilization or Mdm2 relocalization. Mol Cell Biol. 2002;22:196–206.
Google Scholar
Lohrum MAE, Ashcroft M, Kubbutat MHG, Vousden KH. Contribution of two independent MDM2-binding domains in p14ARF to p53 stabilization. Curr Biol. 2000;10:539–42.
Google Scholar
Jacobsson PA, Eneroth GM, Killander D, Moberger G, Martensson B. Histologic classification and grading of malignancy in carcinoma of the larynx. Acta Radio. 1973;12:1–7.
Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA Jr, Butel JS, et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature. 1992;356:215–21.
Google Scholar
Saba Y, Aizenbud I, Matanes D, Koren N, Barel O, Zubeidat K, et al. Early antitumor activity of oral Langerhans cells is compromised by a carcinogen. Proc Natl Acad Sci USA 2022;119:e2118424119.
Google Scholar
Zeng Y, Kotake Y, Pei XH, Smith MD, Xiong Y. p53 binds to and is required for the repression of Arf tumor suppressor by HDAC and Polycomb. Cancer Res. 2011;71:2781–92.
Google Scholar
Yamakoshi K, Takahashi A, Hirota F, Nakayama R, Ishimaru N, Kubo Y, et al. Real-time in vivo imaging of p16Ink4a reveals cross talk with p53. J Cell Biol. 2009;186:393–407.
Google Scholar
Stiewe T, Pützer BM. Role of the p53-homologue p73 in E2F1-induced apoptosis. Nat Genet. 2000;26:464–9.
Google Scholar
Qin Z, Liu H, Sheng Q, Dan J, Wu X, Li H, et al. Mutant p53 leads to low-grade IFN-I-induced inflammation and impairs cGAS–STING signalling in mice. Eur J Immunol. 2023;53:e2250211.
Google Scholar
Deneka AY, Baca Y, Serebriiskii IG, Nicolas E, Parker MI, Nguyen TT, et al. Association of TP53 and CDKN2A mutation profile with tumor mutation burden in head and neck cancer. Clin Cancer Res. 2022;28:1925–37.
Google Scholar
Mandal R, Şenbabaoğlu Y, Desrichard A, Havel JJ, Dalin MG, Riaz N, et al. The head and neck cancer immune landscape and its immunotherapeutic implications. JCI Insight. 2016;1:e89829.
Google Scholar
Motwani M, Pesiridis S, Fitzgerald KA. DNA sensing by the cGAS–STING pathway in health and disease. Nat Rev Genet. 2019;20:657–74.
Google Scholar
Punovuori K, Bertillot F, Miroshnikova YA, Binner MI, Myllymäki S-M, Follain G, et al. Multiparameter imaging reveals clinically relevant cancer cell-stroma interaction dynamics in head and neck cancer. Cell. 2024;187:7267–84.
Google Scholar
